[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1073/pnas.86.11.4027; PubMed=2726765 [NCBI, ExPASy, EBI, Israel, Japan]
Franke W.W.,
Goldschmidt M.D.,
Zimbelmann R.,
Mueller H.M.,
Schiller D.L.,
Cowin P.;
"Molecular cloning and amino acid sequence of human plakoglobin, the common junctional plaque protein.";
Proc. Natl. Acad. Sci. U.S.A. 86:4027-4031(1989).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
Zimbelmann R.;
Submitted (DEC-1995) to the EMBL/GenBank/DDBJ databases.
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
DOI=10.1034/j.1600-0625.2000.009005323.x; PubMed=11016852 [NCBI, ExPASy, EBI, Israel, Japan]
Whittock N.V.,
Eady R.A.J.,
McGrath J.A.;
"Genomic organization and amplification of the human plakoglobin gene (JUP).";
Exp. Dermatol. 9:323-326(2000).
|
[4]
|
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-697.
TISSUE=Epidermal carcinoma;
Liang X.-J.,
Gottesman M.M.;
"Homo sapiens gamma-catenin mRNA from human KB epidermoid adenocarcinoma cells.";
Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT LEU-697.
Mural R.J.,
Istrail S.,
Sutton G.G.,
Florea L.,
Halpern A.L.,
Mobarry C.M.,
Lippert R.,
Walenz B.,
Shatkay H.,
Dew I.,
Miller J.R.,
Flanigan M.J.,
Edwards N.J.,
Bolanos R.,
Fasulo D.,
Halldorsson B.V.,
Hannenhalli S.,
Turner R.,
Yooseph S.,
Lu F.,
Nusskern D.R.,
Shue B.C.,
Zheng X.H.,
Zhong F.,
Delcher A.L.,
Huson D.H.,
Kravitz S.A.,
Mouchard L.,
Reinert K.,
Remington K.A.,
Clark A.G.,
Waterman M.S.,
Eichler E.E.,
Adams M.D.,
Hunkapiller M.W.,
Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-697.
TISSUE=Lung, and Placenta;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan] The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[7]
|
PROTEIN SEQUENCE OF 1-12; 116-142; 150-172; 177-203; 217-233; 273-279; 304-320; 327-333; 368-394; 427-460; 466-533; 583-602; 638-661 AND 664-674, ACETYLATION AT MET-1, AND MASS SPECTROMETRY.
TISSUE=Cervix carcinoma, and Lung carcinoma;
Bienvenut W.V.,
Vousden K.H.,
Lukashchuk N.,
Calvo F.,
Kolch W.;
Submitted (MAR-2008) to UniProtKB.
|
[8]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 634-745, VARIANT LEU-697, AND INVOLVEMENT IN NAXOS DISEASE.
TISSUE=Leukocyte;
DOI=10.1016/S0140-6736(00)02379-5; PubMed=10902626 [NCBI, ExPASy, EBI, Israel, Japan]
McKoy G.,
Protonotarios N.,
Crosby A.,
Tsatsopoulou A.,
Anastasakis A.,
Coonar A.,
Norman M.,
Baboonian C.,
Jeffery S.,
McKenna W.J.;
"Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease).";
Lancet 355:2119-2124(2000).
|
[9]
|
INTERACTION WITH MUC1.
DOI=10.1074/jbc.272.19.12492; PubMed=9139698 [NCBI, ExPASy, EBI, Israel, Japan]
Yamamoto M.,
Bharti A.,
Li Y.,
Kufe D.;
"Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion.";
J. Biol. Chem. 272:12492-12494(1997).
|
[10]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1074/mcp.M500089-MCP200; PubMed=15951569 [NCBI, ExPASy, EBI, Israel, Japan]
Zhang Y.,
Wolf-Yadlin A.,
Ross P.L.,
Pappin D.J.,
Rush J.,
Lauffenburger D.A.,
White F.M.;
"Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.";
Mol. Cell. Proteomics 4:1240-1250(2005).
|
[11]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-182 AND SER-665, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1016/j.cell.2006.09.026; PubMed=17081983 [NCBI, ExPASy, EBI, Israel, Japan]
Olsen J.V.,
Blagoev B.,
Gnad F.,
Macek B.,
Kumar C.,
Mortensen P.,
Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.";
Cell 127:635-648(2006).
|
[12]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-660, AND MASS SPECTROMETRY.
DOI=10.1016/j.cell.2007.11.025; PubMed=18083107 [NCBI, ExPASy, EBI, Israel, Japan]
Rikova K.,
Guo A.,
Zeng Q.,
Possemato A.,
Yu J.,
Haack H.,
Nardone J.,
Lee K.,
Reeves C.,
Li Y.,
Hu Y.,
Tan Z.,
Stokes M.,
Sullivan L.,
Mitchell J.,
Wetzel R.,
Macneill J.,
Ren J.M.,
Yuan J.,
Bakalarski C.E.,
Villen J.,
Kornhauser J.M.,
Smith B.,
Li D.,
Zhou X.,
Gygi S.P.,
Gu T.-L.,
Polakiewicz R.D.,
Rush J.,
Comb M.J.;
"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.";
Cell 131:1190-1203(2007).
|
[13]
|
IDENTIFICATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
Colinge J.,
Superti-Furga G.,
Bennett K.L.;
Submitted (OCT-2008) to UniProtKB.
|
[14]
|
VARIANT ARVD12 SER-39 INS, AND CHARACTERIZATION OF VARIANT ARVD12 SER-39 INS.
DOI=10.1086/521633; PubMed=17924338 [NCBI, ExPASy, EBI, Israel, Japan]
Asimaki A.,
Syrris P.,
Wichter T.,
Matthias P.,
Saffitz J.E.,
McKenna W.J.;
"A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy.";
Am. J. Hum. Genet. 81:964-973(2007).
|
|